Akari Therapeutics (AKTX) vs NewcelX (NCEL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Akari Therapeutics (AKTX) has outperformed NewcelX (NCEL) over the past year, losing 79.5% versus a loss of 83.4%. Over five years, AKTX leads with a -99.3% price change compared with -99.7% for NCEL. Akari Therapeutics is the larger company by market cap ($19.2 million vs $17.0 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AKTX | NCEL |
|---|---|---|
| Share price | $8.42 | $2.95 |
| Market cap | $19.24M | $17.01M |
| 1-day change | -2.38% | -2.97% |
| YTD return | -25.39% | +59.74% |
| 1-year return | -79.46% | -83.42% |
| 5-year return | -99.35% | -99.69% |
| P/E ratio (TTM) | — | 5.66 |
| EPS (TTM) | $0.00 | $0.52 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $42.80 | $19.07 |
| 52-week low | $3.02 | $1.83 |
| Distance from 52-week high | -80.33% | -84.56% |
| Average volume | 60.35K | 12.22K |
| Shares outstanding | 2.29M | 5.78M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
AKTX vs NCEL FAQ
Which is bigger, Akari Therapeutics or NewcelX?
Akari Therapeutics (AKTX) is larger, with a market capitalization of $19.24M compared with $17.01M for NewcelX (NCEL).
Which stock has performed better over the past year, AKTX or NCEL?
AKTX returned -79.46% over the past 12 months, compared with -83.42% for NCEL (price return, excluding dividends). Past performance does not predict future results.
Are Akari Therapeutics and NewcelX in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.